Medexus Pharmaceuticals Inc.
MEDXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$315 | $516 | -$553 | $733 |
| Dep. & Amort. | $2,428 | $2,426 | $2,436 | $1,756 |
| Deferred Tax | -$12 | $99 | -$206 | $147 |
| Stock-Based Comp. | -$122 | $167 | $116 | $7 |
| Change in WC | -$290 | $580 | $619 | $1,294 |
| Other Non-Cash | $1,648 | $131 | -$136 | $2,773 |
| Operating Cash Flow | $3,337 | $3,919 | $2,276 | $6,710 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$125 | -$53 | -$61 |
| Net Acquisitions | -$1,648 | -$369 | -$2,010 | -$375 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$1,847 | $0 | -$43 |
| Investing Cash Flow | -$1,655 | -$2,341 | -$2,063 | -$479 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,157 | -$15,552 | -$3,357 | -$3,359 |
| Stock Issued | $0 | $0 | $19,162 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$442 | -$739 | -$639 | -$1,102 |
| Financing Cash Flow | -$1,599 | -$16,291 | $15,166 | -$4,461 |
| Forex Effect | -$34 | $72 | $153 | -$302 |
| Net Chg. in Cash | $49 | -$14,641 | $15,532 | $1,468 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,332 | $23,973 | $8,441 | $6,973 |
| End Cash | $9,381 | $9,332 | $23,973 | $8,441 |
| Free Cash Flow | $3,330 | $3,794 | $2,223 | $6,606 |